EGFR and non-small cell lung carcinoma: We analysed the protein landscape of EVs and cells of an in vitro osimertinib responsive and a resistant NSCLC cell line pair expressing the EGFR T790M mutation, and from EVs isolated from serum of NSCLC patients within the phase II clinical trial TREM (Eide et al.